Posts Tagged waiver

Attention Primary Care Providers: Alcohol and Drug Conference is March 19-21

Attention Primary Care Providers: Alcohol and Drug Conference is March 19-21

 

See also: Are You Interested in Becoming a DATA-Waived Physician?

Alabama Department of Mental Health has partnered with the Alabama Department of Public Health on a grant to increase awareness of substance use disorders among primary care professionals. This grant will allow ADMH to pay the registration fee only for any of the following to attend the Alabama School of Alcohol and Other Drug Studies (ASADS):

  • MD
  • DO
  • PA
  • CRNP
  • CNM
  • RN

The Medical Foundation of Alabama designates this live activity for a maximum of 27 AMA PRA Category 1 Credit(s)™.

ASADS has been conducting conferences for over 43 years. Over the past couple of years, there has been a heavy emphasis in the community and at the state level to begin to develop a system of care that integrates primary care and substance abuse treatment. There are many great speakers at this year’s conference.

Dr. Alta DeRoo, M.D., FACOG, will present Medication Assisted Treatment (MAT) Waiver Training. This is required 8-hour training.

T4: Medication Assisted Treatment (MAT) Waiver Training

This course is designed for MDs, DOs, PAs and CRNPs who are interested in becoming a 2000 Data Waived physician. This class will be held from 8 a.m. – 5 p.m. to meet the 8-hour requirement.

Course Description:

This presentation is designed to train qualified physicians in dispensing or prescribing specifically approved Schedule III, IV and V narcotic medications for the treatment of opioid addiction in an office-based setting. The goal of this training is to acquire the knowledge and skills needed to provide optimal care to opioid use disorder patients by providing:

1) an overview of opioid use disorder,

2) the efficacy and safety of buprenorphine,

3) process of patient selection,

4) clinical use of buprenorphine,

5) nonpharmacological interventions,

6) medical psychiatric conditions in opioid use disorder patients, office procedures, and

7) special treatment population.

This eight-hour training, which will include eight separate modules and four case studies. Each of the speakers will be presenting for two hours. The remaining two hours are broken up over the four case studies. Designated by the DHHS, this training meets the eight-hour requirement and is designed for physicians to dispense buprenorphine in office practice for treatment of opioid use disorder. Participation in this training will provide physicians with a comprehensive overview of buprenorphine prescribing and its safe and effective use in an office-based setting. This training is designed for physicians and other primary care providers who are likely to treat opioid-dependent persons in their practice, such as those in family practice, general internal medicine, psychiatry, pediatrics, adolescent medicine specialists, and Opioid Treatment Programs.

Course Objectives:

After attending the course, a participant will be able to:

• review addiction treatment in office-based practices;

• discuss the pharmacological treatments of opioid use disorder;

• determine what medical record documentation must be followed;

• discuss the process of buprenorphine induction as well as stabilization and maintenance techniques;

• describe how to take a patient history and evaluation; and

• review safety concerns and drug interactions.

Dr. Merrill Norton, Ph.D., will be conducting a three-part series on The Pain of Pleasure: A Pharmacist’s Guide to Opioid Use Disorders for Prescribers and Other Healthcare Professionals.

Dr. Cardwell Nuckols, Ph.D.The Neurobiology of Addiction: The Addiction Process in Three Stages

Dr. Boyett, D.M.D., D.O., DFASAM, and Dr. Taylor, M.D., M.P.H., F.A.S.A.MThe Delivery of Office-Based Addiction Treatment (OBOT) in the 21st Century

ADMH can pay the registration fee only. To have your registration fee paid, complete the registration form and return it to Kathy House at kathy.house@mh.alabama.gov no later than Feb. 24.

REGISTRATION FORM           BROCHURE

See also: Are You Interested in Becoming a DATA-Waived Physician?

Posted in: Education

Leave a Comment (0) →

HIPAA Guidance for Mass Shootings and Other Tragic and Emergency Situations

HIPAA Guidance for Mass Shootings and Other Tragic and Emergency Situations

In the aftermath of one of the deadliest school shootings in U.S. history, many health care organizations are revisiting their HIPAA policies and procedures to determine exactly what information they are allowed to share and to whom they may share information. 

FAMILY AND FRIENDS

A health care entity may share a patient’s location, general condition or death with a patient’s family, guardian, or friend who is involved in the patient’s care or who may be responsible for payment of the patient’s treatment. This may occur in a variety of circumstances including, but not limited to, the following:

  • If the patient is present and able to consent to the disclosure, the health care provider must obtain the patient’s consent, provide the patient with the opportunity to object to the disclosure, or based on the professional judgment of the health care professional, they may reasonably conclude that the individual would not object to the disclosure being made.
  • If the patient is not present or unable to consent due to incapacity or emergency, the health care professional may in the exercise of professional judgment determine whether the disclosure to the family, friend or guardian is in the best interest of the patient.
  • If the patient is deceased, the health care provider may disclose information about the patient to the family member, friend or guardian unless the health care professional is specifically aware that the patient expressed that the disclosure not be made prior to their death.
  • Health care providers may also share information about a patient with police, media outlets or the general public when attempting to identify, locate or notify family members, guardians or personal representatives of a patient. Information that may be shared include the patient’s location, general health status or death.
  • PHI may be shared with disaster relief organizations that are legally responsible for assisting with disasters if doing so will assist in the notification of family members or other individuals responsible for the patient’s care. [1]

MEDIA OUTLETS

Hospitals and health care entities may share general information about a patient with media outlets in an effort to identify, locate or notify individuals responsible for the patient’s care. However, if the request is initiated by the media, you must consider the following:

  • If the patient is conscious and does not specifically object, limited facility directory information may be shared as long as the requestor identifies the patient by name. This information includes whether the patient is indeed seeking treatment at the facility, whether they are in critical or stable condition, and whether they sought treatment and are now released.
  • If the patient is unable to consent, the health care provider can determine based on their professional judgment whether notifying the media or general public of the patient’s status or death is in the best interest of the patient.

Specific information about a patient’s care, such as x-rays, tests performed and test results, or details of a patient’s diagnosis may not be disclosed without either the patient’s authorization or the authorization of their personal representative.

LAW ENFORCEMENT

Health care entities can provide information to law enforcement with a signed HIPAA authorization from the patient or the patient’s personal representative. However, there are instances in which PHI may be shared with law enforcement without patient consent. Those instances include:

  • When the health care professional reasonably believes that the report would prevent or lessen a serious and imminent threat to the health or safety of an individual or the public;
  • The entity believes in good faith that it is sharing information that may be evidence of a crime that occurred on the premises of the entity;
  • Alerting law enforcement of the death of an individual when there is a suspicion that the death resulted from criminal conduct;
  • When responding to an off-site medical emergency, as necessary to alert law enforcement to criminal activity;
  • When it is required by law to make reports to law enforcement, like in instances of treating gunshot or stab wounds;
  • In compliance with court orders, warrants, subpoenas or summons;
  • In response to a request by law enforcement to identify or locate a suspect, fugitive, material witness or missing person (the information must be limited to basic demographic and identifying information about the person); and
  • Instances of child abuse or neglect reporting when the entity receiving the report is officially authorized by law to receive the report[2].

WHAT ABOUT THE SUSPECT?

When law enforcement needs assistance with identifying and locating a suspect, fugitive or material witness to a crime, health care entities are encouraged to cooperate with these requests.  However, those disclosures must be limited to the following information:

  • Name and Address,
  • Date and Place of Birth,
  • Social Security Number,
  • ABO Blood Type and RH Factor,
  • Type of Injury,
  • Date and Time of Treatment,
  • Date and Time of Death, and
  • Description of Distinguishing Physical Characteristics[3] (Ex. Tattoos, mustache, beard).

Any additional disclosures about a suspect’s medical information, such as DNA tests or body fluid analysis, can only be disclosed upon the presentation of a signed authorization, court order, warrant or documented administrative request.

WHAT IS A HIPAA WAIVER, AND WHEN DOES IT APPLY?

There is no lack of confusion regarding what a HIPAA waiver is and when it may be utilized. Waivers of HIPAA sanctions and penalties occur when the President declares an emergency or disaster and the Secretary of the Department of Health and Human Services (HHS) waives provisions of the Privacy Rule during the emergency or disaster.

If the Secretary issues such a waiver, it only applies:

  • In the emergency area and for the emergency period identified in the public health emergency declaration;
  • To hospitals that have instituted a disaster protocol. The waiver would only apply to patients at such hospital; and
  • For up to 72 hours from the time the hospital implements its disaster protocol.[4] Once the limited waiver terminates, health care entities are required to comply with the HIPAA Privacy Rule.

It is important to know under what circumstances you can disclose information and to whom those disclosures can be offered. Failure to understand these requirements may place you at risk for HIPAA violations and sanctions. If you have specific questions about disclosures of PHI, please contact a health care compliance professional.

[1] 45 CFR 164.510(b)

[2] 45 CFR 164.512

[3] 45 CFR 164.512(f)(2)

[4] 45 CFR 164.510(b)(4)

Article contributed by Samarria Dunson, J.D., CHC, CHPCattorney/principal of The Dunson Group, LLC, a health care compliance consulting and law firm in Montgomery, Ala. The Dunson Group, LLC, is an official partner with the Medical Association.

Posted in: HIPAA

Leave a Comment (0) →

Alabama Medicaid Seeks Public Comments

Alabama Medicaid Seeks Public Comments

Alabama Medicaid is seeking public comment on an amendment to the Alabama Home and Community-Based Intellectual Disabilities Waiver.

Medicaid Intellectual Disabilities Waiver Amendment | Comments Submitted by October 8, 2017

The Alabama Medicaid Agency is seeking public comment on its proposal to amend the Alabama Home and Community-Based Intellectual Disabilities Waiver (ID Waiver).

The waiver supports Alabama citizens who have a diagnosis of Intellectual Disabilities and who would otherwise require the level of care offered in an Intermediate Care Facility for Individuals with Intellectual Disabilities (ICF/IID) institution to remain in the community. The waiver provides services such as day services and in-home supports. The amendment proposes changes to the sections pertaining to Individual Directed Goods and Services and self-directed services.

A copy of the proposed application can be found on the Alabama Medicaid Agency website. Click here to view waiver documents.

The comment period is open until October 8, 2017. Written comment regarding the proposed waiver amendment are welcome and should be mailed to Samantha McLeod, Associate Director via mail to: Alabama Medicaid Agency, Long Term Care Division, P.O. Box 5624, Montgomery, AL 36103-5624 or via email to samantha.mcleod@medicaid.alabama.gov.

Posted in: Medicaid

Leave a Comment (0) →